HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS: MANUFACTURING STRATEGIES, CONTAINMENT TECHNOLOGIES, AND OCCUPATIONAL SAFETY CONSIDERATIONS

The increasing demand for targeted therapies in oncology and rare diseases has driven the rapid expansion of high-potency active pharmaceutical ingredient (HPAPI) manufacturing. These compounds, characterized by occupational exposure limits (OELs) below 10 μg/m³ and often in the nanogram range, require specialized engineering controls, toxicological assessment, and occupational safety programs. This review examines current HPAPI manufacturing strategies, focusing on containment technologies, health-based exposure limits, and regulatory requirements. The derivation of health-based limits such as Permitted Daily Exposure (PDE) and Occupational Exposure Limits (OELs) forms the foundation of risk assessment, supported by Occupational Exposure Banding (OEB) for early-stage compounds. Facility architecture relies on the "Onion Model" of containment, integrating negative-pressure HVAC systems with 100% single-pass air, HEPA filtration, and Bag-In/Bag-Out (BIBO) housings. Primary containment includes rigid barrier isolators, split butterfly valves (SBVs), and rapid transfer ports (RTPs) for OEB 4 and 5 substances. Critical unit operations—micronization, weighing, dispensing—are performed within fully enclosed systems to prevent airborne release. Cleaning validation has shifted from traditional limits to health-based exposure limits (HBELs), utilizing Maximum Allowable Carryover (MACO) calculations based on PDE values. Occupational safety programs incorporate powered air-purifying respirators (PAPRs), double-gloving, medical surveillance, and real-time industrial hygiene monitoring. Emerging digital tools, including computational fluid dynamics (CFD) and digital twins, enable predictive containment design and continuous monitoring. Successful HPAPI manufacturing integrates robust toxicology, advanced engineering controls, and comprehensive occupational health programs to protect workers and ensure product quality.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-05-01
DOI
https://doi.org/10.5281/zenodo.19876740
Primary Topic
Safe Handling of Antineoplastic Drugs
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS: MANUFACTURING STRATEGIES, CONTAINMENT TECHNOLOGIES, AND OCCUPATIONAL SAFETY CONSIDERATIONS

Vishal Shah*
Zenodo (CERN European Organization for Nuclear Research)
Safe Handling of Antineoplastic Drugs
article

HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS: MANUFACTURING STRATEGIES, CONTAINMENT TECHNOLOGIES, AND OCCUPATIONAL SAFETY CONSIDERATIONS

Vishal Shah*
article en

Abstract

The increasing demand for targeted therapies in oncology and rare diseases has driven the rapid expansion of high-potency active pharmaceutical ingredient (HPAPI) manufacturing. These compounds, characterized by occupational exposure limits (OELs) below 10 μg/m³ and often in the nanogram range, require specialized engineering controls, toxicological assessment, and occupational safety programs. This review examines current HPAPI manufacturing strategies, focusing on containment technologies, health-based exposure limits, and regulatory requirements. The derivation of health-based limits such as Permitted Daily Exposure (PDE) and Occupational Exposure Limits (OELs) forms the foundation of risk assessment, supported by Occupational Exposure Banding (OEB) for early-stage compounds. Facility architecture relies on the "Onion Model" of containment, integrating negative-pressure HVAC systems with 100% single-pass air, HEPA filtration, and Bag-In/Bag-Out (BIBO) housings. Primary containment includes rigid barrier isolators, split butterfly valves (SBVs), and rapid transfer ports (RTPs) for OEB 4 and 5 substances. Critical unit operations—micronization, weighing, dispensing—are performed within fully enclosed systems to prevent airborne release. Cleaning validation has shifted from traditional limits to health-based exposure limits (HBELs), utilizing Maximum Allowable Carryover (MACO) calculations based on PDE values. Occupational safety programs incorporate powered air-purifying respirators (PAPRs), double-gloving, medical surveillance, and real-time industrial hygiene monitoring. Emerging digital tools, including computational fluid dynamics (CFD) and digital twins, enable predictive containment design and continuous monitoring. Successful HPAPI manufacturing integrates robust toxicology, advanced engineering controls, and comprehensive occupational health programs to protect workers and ensure product quality.

Zenodo (CERN European Organization for Nuclear Research)
Industry, innovation and infrastructure
Openalex Percentile: Top 3%
Safe Handling of Antineoplastic Drugs
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.